PubMed Burrows, L.J., Goldstein, A.T., & Goldstein, I
GLP-1 treatment was not statistically significantly different compared to control at reducing the risk of developing dry AMD at one and three years after treatment, but GLP-1 receptor agonists did lower dry AMD risk at five and 10 years after treatment by 9.2% and 14.9%, respectively
In 2026, it remains the most evidence-backed carrier peptide in cosmetic science
Ingredients: glycerin, aqua/water/eau, polyglyceryl-10 dipalmitate, sea salt, phenoxyethanol, caprylyl glycol, sodium lauroamphoacetate, sodium trideceth sulfate, parfum/fragrance, linalool, tocopheryl acetate, butylene glycol, panthenol, isopropyl alcohol, geraniol, algae extract, fucus vesiculosus extract, macrocystis pyrifera (kelp) extract, plankton extract, citric acid, fd & c yellow no
Wilding, John P